During the working visit to London between the FBU "State Institute of Medicines and Good Practices" of the Ministry of Industry and Trade of the Russian Federation and the Agency for the Regulation of Medicines and Health Products of the United Kingdom of Great Britain and Northern Ireland (MHRA, Medicines and Healthcare products Regulatory Agency) a memorandum of cooperation in the evaluation of drug manufacturers with the requirements of good manufacturing practice rules.